Loading...
XHKG2666
Market cap1.18bUSD
Dec 23, Last price  
4.85HKD
1D
1.68%
1Q
6.13%
Jan 2017
-24.34%
IPO
-29.81%
Name

Genertec Universal Medical Group Co Ltd

Chart & Performance

D1W1MN
XHKG:2666 chart
P/E
4.08
P/S
0.63
EPS
1.12
Div Yield, %
6.45%
Shrs. gr., 5y
3.95%
Rev. gr., 5y
26.02%
Revenues
13.65b
+18.02%
984,020,0001,556,761,0002,195,202,0002,708,715,0003,423,980,0004,295,013,0006,746,812,0008,243,234,0009,566,906,00011,565,809,00013,650,203,000
Net income
2.11b
+7.68%
312,738,000456,638,000658,526,000872,310,0001,148,658,0001,352,173,0001,588,336,0001,747,137,0001,947,730,0001,959,820,0002,110,337,000
CFO
4.99b
+142.76%
-4,119,417,000-4,110,715,000-4,452,389,000-2,381,645,000-5,072,151,000-5,728,645,000-1,823,905,000-971,721,000-1,400,570,0002,057,196,0004,993,965,000
Dividend
Jun 12, 20240.35 HKD/sh
Earnings
Mar 25, 2025

Profile

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance and Advisory and Hospital Group. The Finance and Advisory segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Hospital Group segment engages in the provision of medical services; hospital and healthcare management; and import and export trading businesses, as well as trading of medical-related goods. The company is also involved in the provision of medical technology; hospital digitalization, construction, and management services; property management; and medical consulting services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China.
URL
https://www.umcare.cn/
IPO date
Jul 08, 2015
Employees
20,048
Domiciled in
CN
Incorporated in
HK

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
13,650,203
18.02%
11,565,809
20.89%
9,566,906
16.06%
Cost of revenue
10,643,948
8,814,995
6,942,437
Unusual Expense (Income)
NOPBT
3,006,255
2,750,814
2,624,469
NOPBT Margin
22.02%
23.78%
27.43%
Operating Taxes
667,141
616,759
661,339
Tax Rate
22.19%
22.42%
25.20%
NOPAT
2,339,114
2,134,055
1,963,130
Net income
2,110,337
7.68%
1,959,820
0.62%
1,947,730
11.48%
Dividends
(591,999)
(580,461)
(482,981)
Dividend yield
6.33%
5.90%
4.21%
Proceeds from repurchase of equity
31,590,281
BB yield
-275.36%
Debt
Debt current
22,453,360
20,802,790
15,140,785
Long-term debt
33,470,422
26,999,843
33,961,931
Deferred revenue
28,926
13,481
12,093
Other long-term liabilities
30,382,940
(26,009,916)
(28,854,653)
Net debt
52,353,934
40,749,611
43,855,465
Cash flow
Cash from operating activities
4,993,965
2,057,196
(1,400,570)
CAPEX
(896,833)
(608,091)
(385,066)
Cash from investing activities
(1,058,997)
(128,881)
(664,522)
Cash from financing activities
(3,793,636)
(1,565,719)
2,391,778
FCF
1,654,696
(5,216,398)
7,226,284
Balance
Cash
2,848,973
2,679,426
2,342,078
Long term investments
720,875
4,373,596
2,905,173
Excess cash
2,887,338
6,474,732
4,768,906
Stockholders' equity
20,367,958
19,703,013
17,623,255
Invested Capital
68,878,880
63,994,982
50,013,437
ROIC
3.52%
3.74%
3.56%
ROCE
4.13%
2.85%
3.14%
EV
Common stock shares outstanding
2,082,889
2,077,100
2,037,750
Price
4.49
-5.27%
4.74
-15.81%
5.63
-3.10%
Market cap
9,352,173
-5.01%
9,845,455
-14.18%
11,472,535
15.05%
EV
64,723,891
54,667,550
58,185,426
EBITDA
3,514,920
3,189,165
2,943,933
EV/EBITDA
18.41
17.14
19.76
Interest
39,054
35,319
29,132
Interest/NOPBT
1.30%
1.28%
1.11%